Fingerprint
Dive into the research topics of 'A phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms, and chronic myelomonocytic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically